pharmaceutical and biological preparations for the treatment and prevention of diseases in humans, namely, cardiovascular disease, epilepsy, mitochondrial disease, central nervous system disease, infectious disease, acute respiratory disease, and rare diseases; pharmaceutical preparations, namely, a drug formulation for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, oncology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation for use in pediatric, geriatric, emergency, family, and psychiatry; pharmaceutical preparations for the treatment of infectious and hereditary diseases; pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, and the integumentary system; pharmaceutical preparations for the treatment or prevention of muscle loss, metabolic conditions and diseases, gastrointestinal conditions and diseases, neurological conditions and diseases, cancer, osteoporosis, inflammatory conditions and diseases, genetic conditions and diseases, muscle diseases and disorders, hepatic conditions and diseases, fibrosis, malnutrition, atrophic diseases and conditions, epilepsy, sarcopenia, myopathies, neuropathies, neurodegenerative diseases, traumatic brain injury, concussion, movement disorders, dystrophies, anemias, and orphan diseases; pharmaceutical and biological preparations, namely, precision therapeutics; pharmaceutical and biological preparations, namely, large molecule precision therapeutics